MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin

MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: A systematic review and meta-analysis

(2015) Zahra Jamali et al.   ORAL ONCOLOGY

MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity

(2015) Zewu Li et al.   PLoS One

MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells

(2015) Ningwei Li et al.   PLoS One

MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1

(2014) Xiao-nan Chen et al.   Cancer Cell International

Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11

(2014) R. M. Drayton et al.   CLINICAL CANCER RESEARCH

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

(2014) Heng Li et al.   Molecular Cancer

MicroRNA Expression Signatures during Malignant Progression from Barrett's Esophagus to Esophageal Adenocarcinoma

(2013) X. Wu et al.   Cancer Prevention Research

MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells

(2013) Fang Wang et al.   FEBS LETTERS

MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma

(2013) Jianguo He et al.   JOURNAL OF SURGICAL ONCOLOGY

miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase

(2013) Yunfei Zhou et al.   Molecular Oncology

A Bmi1-miRNAs Cross-Talk Modulates Chemotherapy Response to 5-Fluorouracil in Breast Cancer Cells

(2013) Jiang Yin et al.   PLoS One

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

(2012) Iver Nordentoft et al.   BMC Medical Genomics

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings

(2012) Cora N. Sternberg et al.   EUROPEAN UROLOGY

Enhancement of Cisplatin Sensitivity in Lung Cancer Xenografts by Liposome-Mediated Delivery of the Plasmid Expressing Small Hairpin RNA Targeting Survivin

(2012) Hongwei Tian et al.   Journal of Biomedical Nanotechnology

microRNAs in cancer management

(2012) Yi W Kong et al.   LANCET ONCOLOGY

YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels

(2012) B. Kumar et al.   MOLECULAR CANCER THERAPEUTICS

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression

(2011) Jian Li et al.   CANCER LETTERS

Curcumin Modulates MicroRNA-203-Mediated Regulation of the Src-Akt Axis in Bladder Cancer

(2011) S. Saini et al.   Cancer Prevention Research

MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status

(2011) Ruth L. Vinall et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells

(2010) N Bhatnagar et al.   Cell Death & Disease

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

MicroRNAs and Cancer: Short RNAs Go a Long Way

(2009) Andrea Ventura et al.   CELL

Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study

(2009) S. F. Shariat et al.   CLINICAL CANCER RESEARCH

MicroRNAs: Novel Biomarkers for Human Cancer

(2009) C. L. Bartels et al.   CLINICAL CHEMISTRY